It is now universally accepted that Helicobacter pylori is the major etiological agent of chronic type B gastritis (5, 7, 13) and that it may also be involved in the pathogenesis of peptic ulcer disease (12, 17 E test strips containing ampicillin, aztreonam, cefaclor, cefuroxime, ciprofloxacin, clindamycin, erythromycin, gentamicin, metronidazole, nitrofurantoin, oxacillin, and tetracycline were purchased from AB Biodisk (Solna, Sweden) for the purpose of this study. Reagent-grade powders of the same antimicrobial agents were used for agar dilution MIC tests. All antimicrobial solutions were prepared within 2 days of use according to the procedure of the manufacturer. Sixty consecutive nonduplicate clinical strains of H. pylori isolated from gastric antral biopsies and identified by accepted criteria (7) were used. In addition, a collection of 19 selected strains of H. pylori with various resistance patterns and levels of antimicrobial susceptibility was also utilized for this evaluation: 10 strains resistant to metronidazole (MIC. >32 ,ug/ml), 4 resistant to erythromycin (MIC, >64 ,ug/ml) and clindamycin (MIC, >64 pugIml), 4 resistant to ciprofloxacin (MIC, .4 , ug/ml), and 1 resistant both to metronidazole (MIC, >32 pg/ml) and to ciprofloxacin (MIC, 4 ,ug/ml).
The Progressive Diagnostics Manufacturers (PDM) epsilometer test (E test; AB Biodisk, Solna, Sweden) is a new in vitro susceptibility testing method designed for quantitative determination of susceptibility to antimicrobial agents. The E test is a plastic strip containing a predefined, continuous, and exponential antibiotic gradient on one side and a graded continuous MIC scale that covers 15 twofold dilutions on the opposite site. To determine an MIC with the E test, the surface of an agar plate is swab inoculated with an adjusted bacterial suspension in the same manner as for a disk diffusion test. After appropriate incubation time, the interaction of the antimicrobial agent gradient and the tested bacterial inoculum results in an elliptic inhibitory zone which, by use of the MIC scale on the strip, indicates the MIC of the drug for the organism.
It is now universally accepted that Helicobacter pylori is the major etiological agent of chronic type B gastritis (5, 7, 13) and that it may also be involved in the pathogenesis of peptic ulcer disease (12, 17) . The treatment of H. pylori infection is difficult, and it appears from the initial clinical trials that in vitro activity does not always correlate with in vitro success and that relapse frequently occurs after apparently successful elimination of the organism with various antimicrobial agents and/or bismuth salts. Increasing resistance of H. pylori to several classes of antimicrobial agents has further complicated the search for an optimal treatment regimen (6) and has also focused new attention towards reliable methods for determining in vitro susceptibility of this bacterial species.
In fact, there are currently no standard methods nor any optimal procedures for testing the susceptibility of H. pylori to antibiotics, and most investigators have used either the disk diffusion test or the MIC agar dilution technique, because these procedures are usually applied in the micro-* Corresponding author.
biology laboratory for the testing of other microorganisms (15, 16) .
The purpose of this study was to evaluate the E test for determining quantitative susceptibility of H. pylori to antimicrobial agents of possible clinical relevance for this species.
E test strips containing ampicillin, aztreonam, cefaclor, cefuroxime, ciprofloxacin, clindamycin, erythromycin, gentamicin, metronidazole, nitrofurantoin, oxacillin, and tetracycline were purchased from AB Biodisk (Solna, Sweden) for the purpose of this study. Reagent-grade powders of the same antimicrobial agents were used for agar dilution MIC tests. All antimicrobial solutions were prepared within 2 days of use according to the procedure of the manufacturer. Sixty consecutive nonduplicate clinical strains of H. pylori isolated from gastric antral biopsies and identified by accepted criteria (7) were used. In addition, a collection of 19 selected strains of H. pylori with various resistance patterns and levels of antimicrobial susceptibility was also utilized for this evaluation: 10 strains resistant to metronidazole (MIC. >32 ,ug/ml), 4 resistant to erythromycin (MIC, >64 ,ug/ml) and clindamycin (MIC, >64 pugIml), 4 resistant to ciprofloxacin (MIC, .4 ,ug/ml), and 1 resistant both to metronidazole (MIC, >32 pg/ml) and to ciprofloxacin (MIC, 4 ,ug/ml).
These latter strains were isolated from patients who had been enrolled in several treatment trial protocols and for whom MICs for the infecting strain had been previously determined by an agar dilution method (6 (15) .
The results of the E test MICs of the sixty consecutive and nonselected H. pylori strains are shown in Table 1 . Overall, these results are in accordance with those already obtained in various other studies (8, 11, 14) . Fifteen of 60 (25%) strains were found resistant to metronidazole, thus confirming the rather high frequency with which resistance of H. pylori to this antibiotic occurs in the clinic (6, 9) . In most cases, results were easily interpreted for most drugs, since the inhibition ellipses were generally clearly demarcated and the point of intersection of the zone edge with the strip was also well delineated. Reading of the E tests was also without problem for the vast majority of the selected H. pylori strains displaying resistance to one or more antimicrobial agents. However, for metronidazole, some strains yielded growth of numerous small colonies within the inhibition ellipse zone. These colonies were usually clearly identified and were interpreted as resistant isolates. A few strains yielded poorly defined diffuse elliptic inhibition zones, especially with aztreonam, erythromycin, and tetracycline. On repeating these tests, the same phenomenon was usually seen and reproducible, and the MIC result interpretation did not change. In addition, the MIC results of the various antibiotics were always identical or within 1 log2 dilution step for the four strains that were tested with different inocula ranging between 0.5 x 106 and 0.5 x 109 CFU/ml.
The correlation between the results of tests by agar dilution and E test methods for the 12 agents is shown in than 95% (1, 3) . In particular, the E test approach might be interesting for testing fastidious bacteria (10) or bacteria that are difficult to test (e.g., anaerobes [2] ). This test is technically very simple and needs no special equipment, and the methodology is familiar to most laboratories, since tests are performed in a manner that is very similar to the agar disk diffusion method. The stability of the antimicrobial gradient produced by the E test limits the effects of the bacterial inoculum size, preincubation, and prediffusion, which generally have a marked influence on the results of disk diffusion tests (4 However, because of the exquisite susceptibility of H. pylori strains to most antimicrobial agents, no more than four E test strips should be placed on the surface of a 140-mm-diameter round petri dish in order to avoid overlaps between the inhibition zone sizes which would affect the reading of results. Considering the cost of this method (about U.S. $2.50 per test, in Belgium) it is probable that this method will not prove to be very economical, especially for testing a large number of drugs on numerous isolates. It could, however, be worth considering for occasional testing of fastidious bacteria (such as H. pylori) against selected drugs.
